Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hostetter

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of the American Society of Nephrology : JASN|April 6, 2023
Carbamylation in UremiaThomas Hostetter
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2008
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertensionNathaniel Berman, Thomas Hostetter
Journal of the American Society of Nephrology : JASN|October 12, 2018
Broadening Our Perspectives: CKD Care and the Dialysis TransitionThomas Hostetter, Josie P Briggs
The New England Journal of Medicine|January 8, 2015
Physiological approach to assessment of acid-base disturbancesMohamed A Sheta, Thomas Hostetter, Paul Drawz
Clinical Chemistry|August 27, 2002
New markers for kidney diseaseRobert Star, Thomas Hostetter, Glen L Hortin
Clinical Chemistry|October 28, 2006
Automatic reporting of estimated glomerular filtration rate--just what the doctor orderedAndrew S Levey, Lesley A Stevens, Thomas Hostetter
Journal of the American Society of Nephrology : JASN|February 3, 2023
Catalyzing Advocacy and Policies for Patients with Kidney DiseaseJosephine P Briggs, Thomas Hostetter, Neil R Powe
Diabetes|May 31, 2008
Smad1 as a biomarker for diabetic nephropathyHideki Kato, Han Si, Thomas Hostetter, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 10, 2004
National Kidney Disease Education Program in 2004: a program in evolutionThomas Hostetter, Elisa H Gladstone, Domenic A Sica
The Journal of Clinical Investigation|June 4, 2014
Molecular mechanisms of diabetic kidney diseaseKimberly Reidy, Hyun Mi Kang, Thomas Hostetter, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of the American Society of Nephrology : JASN|April 6, 2023
Carbamylation in UremiaThomas Hostetter
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2008
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertensionNathaniel Berman, Thomas Hostetter
Journal of the American Society of Nephrology : JASN|October 12, 2018
Broadening Our Perspectives: CKD Care and the Dialysis TransitionThomas Hostetter, Josie P Briggs
The New England Journal of Medicine|January 8, 2015
Physiological approach to assessment of acid-base disturbancesMohamed A Sheta, Thomas Hostetter, Paul Drawz
Clinical Chemistry|August 27, 2002
New markers for kidney diseaseRobert Star, Thomas Hostetter, Glen L Hortin
Clinical Chemistry|October 28, 2006
Automatic reporting of estimated glomerular filtration rate--just what the doctor orderedAndrew S Levey, Lesley A Stevens, Thomas Hostetter
Journal of the American Society of Nephrology : JASN|February 3, 2023
Catalyzing Advocacy and Policies for Patients with Kidney DiseaseJosephine P Briggs, Thomas Hostetter, Neil R Powe
Diabetes|May 31, 2008
Smad1 as a biomarker for diabetic nephropathyHideki Kato, Han Si, Thomas Hostetter, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 10, 2004
National Kidney Disease Education Program in 2004: a program in evolutionThomas Hostetter, Elisa H Gladstone, Domenic A Sica
The Journal of Clinical Investigation|June 4, 2014
Molecular mechanisms of diabetic kidney diseaseKimberly Reidy, Hyun Mi Kang, Thomas Hostetter, et al.
Pageof 3